APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Vaccine

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Vaccine Market Outlook and Growth Opportunities 2026

Report ID 17392611049 January 2026210 pages

Choose your research edition.

Industry ResearchVeterinary Vaccine Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Vaccine Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Veterinary Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Vaccine Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Vaccine Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Global Veterinary Vaccine key players include Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, etc. Global top five manufacturers hold a share about 75%. North America and Asia Pacific is the largest market, both with a share about 30%, followed by Europe, with a share about 25 percent. In terms of product, Live Attenuated Vaccines is the largest segment, with a share about 60%. And in terms of application, the largest application is Dog & Cat, followed by Livestock, Swine, Chicken, etc.

This report provides an overview of the global Veterinary Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Veterinary Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Vaccine Segment by Company

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CAVAC

Kyoto Biken Laboratories

FATRO

Vaksindo

Bio-Labs

Avimex Animal Health

MEVAC

Biovac

Atafen

Dyntec

BioTestLab

RVSRI

Medion

Veterinary Vaccine Segment by Type

Live Attenuated Vaccines

Inactivated Vaccines

Others

Veterinary Vaccine Segment by Application

Livestock

Swine

Chicken

Dog & Cat

Others

Veterinary Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Vaccine industry.

Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Vaccine Industry Trends Table 2. Veterinary Vaccine Industry Drivers Table 3. Veterinary Vaccine Industry Opportunities and Challenges Table 4. Veterinary Vaccine Industry Restraints Table 5. Global Veterinary Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Vaccine Revenue Share by Company (2021-2026) Table 7. Global Veterinary Vaccine Sales Volume by Company (M Doses) & (2021-2026) Table 8. Global Veterinary Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Vaccine Average Price (USD/Doses) of Company (2021-2026) Table 10. Global Veterinary Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Vaccine Company, Product Type & Application Table 13. Global Veterinary Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Attenuated Vaccines Table 18. Significant Companies of Inactivated Vaccines Table 19. Significant Companies of Others Table 20. Global Veterinary Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (M Doses) Table 21. Global Veterinary Vaccine Sales Volume by Type (2021-2026) & (M Doses) Table 22. Global Veterinary Vaccine Sales Volume by Type (2027-2032) & (M Doses) Table 23. Global Veterinary Vaccine Sales Volume Share by Type (2021-2026) Table 24. Global Veterinary Vaccine Sales Volume Share by Type (2027-2032) Table 25. Global Veterinary Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Veterinary Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Veterinary Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Veterinary Vaccine Sales Value Share by Type (2021-2026) Table 29. Global Veterinary Vaccine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Livestock Table 31. Significant Companies of Swine Table 32. Significant Companies of Chicken Table 33. Significant Companies of Dog & Cat Table 34. Significant Companies of Others Table 35. Global Veterinary Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (M Doses) Table 36. Global Veterinary Vaccine Sales Volume by Application (2021-2026) & (M Doses) Table 37. Global Veterinary Vaccine Sales Volume by Application (2027-2032) & (M Doses) Table 38. Global Veterinary Vaccine Sales Volume Share by Application (2021-2026) Table 39. Global Veterinary Vaccine Sales Volume Share by Application (2027-2032) Table 40. Global Veterinary Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Veterinary Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Veterinary Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Veterinary Vaccine Sales Value Share by Application (2021-2026) Table 44. Global Veterinary Vaccine Sales Value Share by Application (2027-2032) Table 45. Global Veterinary Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 46. Global Veterinary Vaccine Sales by Region (2021-2026) & (M Doses) Table 47. Global Veterinary Vaccine Sales Market Share by Region (2021-2026) Table 48. Global Veterinary Vaccine Sales by Region (2027-2032) & (M Doses) Table 49. Global Veterinary Vaccine Sales Market Share by Region (2027-2032) Table 50. Global Veterinary Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Veterinary Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Veterinary Vaccine Sales Value Share by Region (2021-2026) Table 53. Global Veterinary Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Veterinary Vaccine Sales Value Share by Region (2027-2032) Table 55. Global Veterinary Vaccine Market Average Price (USD/Doses) by Region (2021-2026) Table 56. Global Veterinary Vaccine Market Average Price (USD/Doses) by Region (2027-2032) Table 57. Global Veterinary Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Table 58. Global Veterinary Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 60. Global Veterinary Vaccine Sales Market Share by Country (2021-2026) Table 61. Global Veterinary Vaccine Sales by Country (2027-2032) & (M Doses) Table 62. Global Veterinary Vaccine Sales Market Share by Country (2027-2032) Table 63. Global Veterinary Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Veterinary Vaccine Sales Value Market Share by Country (2021-2026) Table 65. Global Veterinary Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Veterinary Vaccine Sales Value Market Share by Country (2027-2032) Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 70. Merck Veterinary Vaccine Product Portfolio Table 71. Merck Recent Development Table 72. Zoetis Company Information Table 73. Zoetis Business Overview Table 74. Zoetis Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 75. Zoetis Veterinary Vaccine Product Portfolio Table 76. Zoetis Recent Development Table 77. Boehringer Ingelheim Company Information Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 80. Boehringer Ingelheim Veterinary Vaccine Product Portfolio Table 81. Boehringer Ingelheim Recent Development Table 82. Ceva Company Information Table 83. Ceva Business Overview Table 84. Ceva Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 85. Ceva Veterinary Vaccine Product Portfolio Table 86. Ceva Recent Development Table 87. CAHIC Company Information Table 88. CAHIC Business Overview Table 89. CAHIC Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 90. CAHIC Veterinary Vaccine Product Portfolio Table 91. CAHIC Recent Development Table 92. HVRI Company Information Table 93. HVRI Business Overview Table 94. HVRI Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 95. HVRI Veterinary Vaccine Product Portfolio Table 96. HVRI Recent Development Table 97. Ringpu Biology Company Information Table 98. Ringpu Biology Business Overview Table 99. Ringpu Biology Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 100. Ringpu Biology Veterinary Vaccine Product Portfolio Table 101. Ringpu Biology Recent Development Table 102. Yebio Company Information Table 103. Yebio Business Overview Table 104. Yebio Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 105. Yebio Veterinary Vaccine Product Portfolio Table 106. Yebio Recent Development Table 107. DHN Company Information Table 108. DHN Business Overview Table 109. DHN Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 110. DHN Veterinary Vaccine Product Portfolio Table 111. DHN Recent Development Table 112. WINSUN Company Information Table 113. WINSUN Business Overview Table 114. WINSUN Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 115. WINSUN Veterinary Vaccine Product Portfolio Table 116. WINSUN Recent Development Table 117. Elanco Company Information Table 118. Elanco Business Overview Table 119. Elanco Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 120. Elanco Veterinary Vaccine Product Portfolio Table 121. Elanco Recent Development Table 122. Virbac Company Information Table 123. Virbac Business Overview Table 124. Virbac Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 125. Virbac Veterinary Vaccine Product Portfolio Table 126. Virbac Recent Development Table 127. Jinyu Bio-Technology Company Information Table 128. Jinyu Bio-Technology Business Overview Table 129. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 130. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio Table 131. Jinyu Bio-Technology Recent Development Table 132. ChengDu Tecbond Company Information Table 133. ChengDu Tecbond Business Overview Table 134. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 135. ChengDu Tecbond Veterinary Vaccine Product Portfolio Table 136. ChengDu Tecbond Recent Development Table 137. CAVAC Company Information Table 138. CAVAC Business Overview Table 139. CAVAC Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 140. CAVAC Veterinary Vaccine Product Portfolio Table 141. CAVAC Recent Development Table 142. Kyoto Biken Laboratories Company Information Table 143. Kyoto Biken Laboratories Business Overview Table 144. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 145. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio Table 146. Kyoto Biken Laboratories Recent Development Table 147. FATRO Company Information Table 148. FATRO Business Overview Table 149. FATRO Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 150. FATRO Veterinary Vaccine Product Portfolio Table 151. FATRO Recent Development Table 152. Vaksindo Company Information Table 153. Vaksindo Business Overview Table 154. Vaksindo Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 155. Vaksindo Veterinary Vaccine Product Portfolio Table 156. Vaksindo Recent Development Table 157. Bio-Labs Company Information Table 158. Bio-Labs Business Overview Table 159. Bio-Labs Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 160. Bio-Labs Veterinary Vaccine Product Portfolio Table 161. Bio-Labs Recent Development Table 162. Avimex Animal Health Company Information Table 163. Avimex Animal Health Business Overview Table 164. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 165. Avimex Animal Health Veterinary Vaccine Product Portfolio Table 166. Avimex Animal Health Recent Development Table 167. MEVAC Company Information Table 168. MEVAC Business Overview Table 169. MEVAC Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 170. MEVAC Veterinary Vaccine Product Portfolio Table 171. MEVAC Recent Development Table 172. Biovac Company Information Table 173. Biovac Business Overview Table 174. Biovac Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 175. Biovac Veterinary Vaccine Product Portfolio Table 176. Biovac Recent Development Table 177. Atafen Company Information Table 178. Atafen Business Overview Table 179. Atafen Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 180. Atafen Veterinary Vaccine Product Portfolio Table 181. Atafen Recent Development Table 182. Dyntec Company Information Table 183. Dyntec Business Overview Table 184. Dyntec Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 185. Dyntec Veterinary Vaccine Product Portfolio Table 186. Dyntec Recent Development Table 187. BioTestLab Company Information Table 188. BioTestLab Business Overview Table 189. BioTestLab Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 190. BioTestLab Veterinary Vaccine Product Portfolio Table 191. BioTestLab Recent Development Table 192. RVSRI Company Information Table 193. RVSRI Business Overview Table 194. RVSRI Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 195. RVSRI Veterinary Vaccine Product Portfolio Table 196. RVSRI Recent Development Table 197. Medion Company Information Table 198. Medion Business Overview Table 199. Medion Veterinary Vaccine Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 200. Medion Veterinary Vaccine Product Portfolio Table 201. Medion Recent Development Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. Veterinary Vaccine Distributors List Table 205. Veterinary Vaccine Customers List Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Veterinary Vaccine Product Image Figure 2. Global Veterinary Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Vaccine Sales (2021-2032) & (M Doses) Figure 5. Global Veterinary Vaccine Sales Average Price (USD/Doses) & (2021-2032) Figure 6. Global Veterinary Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Attenuated Vaccines Image Figure 10. Inactivated Vaccines Image Figure 11. Others Image Figure 12. Global Veterinary Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 13. Global Veterinary Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Veterinary Vaccine Sales Volume Share by Type (2021-2032) Figure 15. Global Veterinary Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Veterinary Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Veterinary Vaccine Sales Value Share by Type (2021-2032) Figure 18. Livestock Image Figure 19. Swine Image Figure 20. Chicken Image Figure 21. Dog & Cat Image Figure 22. Others Image Figure 23. Global Veterinary Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 24. Global Veterinary Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Veterinary Vaccine Sales Volume Share by Application (2021-2032) Figure 26. Global Veterinary Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Veterinary Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Veterinary Vaccine Sales Value Share by Application (2021-2032) Figure 29. Global Veterinary Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 30. Global Veterinary Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Veterinary Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Veterinary Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Veterinary Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. North America Veterinary Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Veterinary Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Veterinary Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Veterinary Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Veterinary Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Veterinary Vaccine Sales Value (2021-2032) & (US$ Million) Figure 40. South America Veterinary Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Veterinary Vaccine Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Veterinary Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Veterinary Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Veterinary Vaccine Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Veterinary Vaccine Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Others
Applications
  • Livestock
  • Swine
  • Chicken
  • Dog & Cat
  • Others
Companies covered
  • Merck
  • Zoetis
  • Boehringer Ingelheim
  • Ceva
  • CAHIC
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • WINSUN
  • Elanco
  • Virbac
  • Jinyu Bio-Technology
  • ChengDu Tecbond
  • CAVAC
  • Kyoto Biken Laboratories
  • FATRO
  • Vaksindo
  • Bio-Labs
  • Avimex Animal Health
  • MEVAC
  • Biovac
  • Atafen
  • Dyntec
  • BioTestLab
  • RVSRI
  • Medion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Vaccine Market Dynamics
  1. 2.1 Veterinary Vaccine Industry Trends
  2. 2.2 Veterinary Vaccine Industry Drivers
  3. 2.3 Veterinary Vaccine Industry Opportunities and Challenges
  4. 2.4 Veterinary Vaccine Industry Restraints
3 Veterinary Vaccine Market by Company
  1. 3.1 Global Veterinary Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Vaccine Company Product Type and Application
  8. 3.8 Global Veterinary Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Vaccine Market by Type
  1. 4.1 Veterinary Vaccine Type Introduction
  2. 4.1.1 Live Attenuated Vaccines
  3. 4.1.2 Inactivated Vaccines
  4. 4.1.3 Others
  5. 4.2 Global Veterinary Vaccine Sales Volume by Type
  6. 4.2.1 Global Veterinary Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Veterinary Vaccine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Veterinary Vaccine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Veterinary Vaccine Sales Value by Type
  10. 4.3.1 Global Veterinary Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Veterinary Vaccine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Veterinary Vaccine Sales Value Share by Type (2021-2032)
5 Veterinary Vaccine Market by Application
  1. 5.1 Veterinary Vaccine Application Introduction
  2. 5.1.1 Livestock
  3. 5.1.2 Swine
  4. 5.1.3 Chicken
  5. 5.1.4 Dog & Cat
  6. 5.1.5 Others
  7. 5.2 Global Veterinary Vaccine Sales Volume by Application
  8. 5.2.1 Global Veterinary Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Veterinary Vaccine Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Veterinary Vaccine Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Veterinary Vaccine Sales Value by Application
  12. 5.3.1 Global Veterinary Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Veterinary Vaccine Sales Value by Application (2021-2032)
  14. 5.3.3 Global Veterinary Vaccine Sales Value Share by Application (2021-2032)
6 Veterinary Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Vaccine Sales Value Share by Country, 2025 VS 2032
7 Veterinary Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Veterinary Vaccine Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Veterinary Vaccine Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Ceva
  20. 8.4.1 Ceva Company Information
  21. 8.4.2 Ceva Business Overview
  22. 8.4.3 Ceva Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ceva Veterinary Vaccine Product Portfolio
  24. 8.4.5 Ceva Recent Developments
  25. 8.5 CAHIC
  26. 8.5.1 CAHIC Company Information
  27. 8.5.2 CAHIC Business Overview
  28. 8.5.3 CAHIC Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CAHIC Veterinary Vaccine Product Portfolio
  30. 8.5.5 CAHIC Recent Developments
  31. 8.6 HVRI
  32. 8.6.1 HVRI Company Information
  33. 8.6.2 HVRI Business Overview
  34. 8.6.3 HVRI Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 HVRI Veterinary Vaccine Product Portfolio
  36. 8.6.5 HVRI Recent Developments
  37. 8.7 Ringpu Biology
  38. 8.7.1 Ringpu Biology Company Information
  39. 8.7.2 Ringpu Biology Business Overview
  40. 8.7.3 Ringpu Biology Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
  42. 8.7.5 Ringpu Biology Recent Developments
  43. 8.8 Yebio
  44. 8.8.1 Yebio Company Information
  45. 8.8.2 Yebio Business Overview
  46. 8.8.3 Yebio Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Yebio Veterinary Vaccine Product Portfolio
  48. 8.8.5 Yebio Recent Developments
  49. 8.9 DHN
  50. 8.9.1 DHN Company Information
  51. 8.9.2 DHN Business Overview
  52. 8.9.3 DHN Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 DHN Veterinary Vaccine Product Portfolio
  54. 8.9.5 DHN Recent Developments
  55. 8.10 WINSUN
  56. 8.10.1 WINSUN Company Information
  57. 8.10.2 WINSUN Business Overview
  58. 8.10.3 WINSUN Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 WINSUN Veterinary Vaccine Product Portfolio
  60. 8.10.5 WINSUN Recent Developments
  61. 8.11 Elanco
  62. 8.11.1 Elanco Company Information
  63. 8.11.2 Elanco Business Overview
  64. 8.11.3 Elanco Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Elanco Veterinary Vaccine Product Portfolio
  66. 8.11.5 Elanco Recent Developments
  67. 8.12 Virbac
  68. 8.12.1 Virbac Company Information
  69. 8.12.2 Virbac Business Overview
  70. 8.12.3 Virbac Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Virbac Veterinary Vaccine Product Portfolio
  72. 8.12.5 Virbac Recent Developments
  73. 8.13 Jinyu Bio-Technology
  74. 8.13.1 Jinyu Bio-Technology Company Information
  75. 8.13.2 Jinyu Bio-Technology Business Overview
  76. 8.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
  78. 8.13.5 Jinyu Bio-Technology Recent Developments
  79. 8.14 ChengDu Tecbond
  80. 8.14.1 ChengDu Tecbond Company Information
  81. 8.14.2 ChengDu Tecbond Business Overview
  82. 8.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
  84. 8.14.5 ChengDu Tecbond Recent Developments
  85. 8.15 CAVAC
  86. 8.15.1 CAVAC Company Information
  87. 8.15.2 CAVAC Business Overview
  88. 8.15.3 CAVAC Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CAVAC Veterinary Vaccine Product Portfolio
  90. 8.15.5 CAVAC Recent Developments
  91. 8.16 Kyoto Biken Laboratories
  92. 8.16.1 Kyoto Biken Laboratories Company Information
  93. 8.16.2 Kyoto Biken Laboratories Business Overview
  94. 8.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
  96. 8.16.5 Kyoto Biken Laboratories Recent Developments
  97. 8.17 FATRO
  98. 8.17.1 FATRO Company Information
  99. 8.17.2 FATRO Business Overview
  100. 8.17.3 FATRO Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 FATRO Veterinary Vaccine Product Portfolio
  102. 8.17.5 FATRO Recent Developments
  103. 8.18 Vaksindo
  104. 8.18.1 Vaksindo Company Information
  105. 8.18.2 Vaksindo Business Overview
  106. 8.18.3 Vaksindo Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Vaksindo Veterinary Vaccine Product Portfolio
  108. 8.18.5 Vaksindo Recent Developments
  109. 8.19 Bio-Labs
  110. 8.19.1 Bio-Labs Company Information
  111. 8.19.2 Bio-Labs Business Overview
  112. 8.19.3 Bio-Labs Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
  114. 8.19.5 Bio-Labs Recent Developments
  115. 8.20 Avimex Animal Health
  116. 8.20.1 Avimex Animal Health Company Information
  117. 8.20.2 Avimex Animal Health Business Overview
  118. 8.20.3 Avimex Animal Health Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
  120. 8.20.5 Avimex Animal Health Recent Developments
  121. 8.21 MEVAC
  122. 8.21.1 MEVAC Company Information
  123. 8.21.2 MEVAC Business Overview
  124. 8.21.3 MEVAC Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 MEVAC Veterinary Vaccine Product Portfolio
  126. 8.21.5 MEVAC Recent Developments
  127. 8.22 Biovac
  128. 8.22.1 Biovac Company Information
  129. 8.22.2 Biovac Business Overview
  130. 8.22.3 Biovac Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Biovac Veterinary Vaccine Product Portfolio
  132. 8.22.5 Biovac Recent Developments
  133. 8.23 Atafen
  134. 8.23.1 Atafen Company Information
  135. 8.23.2 Atafen Business Overview
  136. 8.23.3 Atafen Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Atafen Veterinary Vaccine Product Portfolio
  138. 8.23.5 Atafen Recent Developments
  139. 8.24 Dyntec
  140. 8.24.1 Dyntec Company Information
  141. 8.24.2 Dyntec Business Overview
  142. 8.24.3 Dyntec Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Dyntec Veterinary Vaccine Product Portfolio
  144. 8.24.5 Dyntec Recent Developments
  145. 8.25 BioTestLab
  146. 8.25.1 BioTestLab Company Information
  147. 8.25.2 BioTestLab Business Overview
  148. 8.25.3 BioTestLab Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 BioTestLab Veterinary Vaccine Product Portfolio
  150. 8.25.5 BioTestLab Recent Developments
  151. 8.26 RVSRI
  152. 8.26.1 RVSRI Company Information
  153. 8.26.2 RVSRI Business Overview
  154. 8.26.3 RVSRI Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 RVSRI Veterinary Vaccine Product Portfolio
  156. 8.26.5 RVSRI Recent Developments
  157. 8.27 Medion
  158. 8.27.1 Medion Company Information
  159. 8.27.2 Medion Business Overview
  160. 8.27.3 Medion Veterinary Vaccine Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 Medion Veterinary Vaccine Product Portfolio
  162. 8.27.5 Medion Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Vaccine Value Chain Analysis
  2. 9.1.1 Veterinary Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Vaccine Sales Mode & Process
  6. 9.2 Veterinary Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Vaccine Distributors
  9. 9.2.3 Veterinary Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst